Masavibart Antibody
Masavibart (ZRC3308-A7) is an IgG1 monoclonal antibody targeting a unique, non-competing epitope on the SARS-CoV-2 spike RBD. In combination with ZRC3308-B10, it shows prophylactic efficacy against early COVID-19, as supported by in vitro neutralization studies and in vivo preclinical models.
Product Specifications
Target
SARS-CoV
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Infectious Disease & Virology
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog